The BioCollective

About:

The BioCollective is an innovation engine for the microbiome providing for contextual solutions to improving health.

Website: http://www.thebiocollective.com/

Twitter/X: TBCMicrobes

Top Investors: National Institute of General Medical Science

Description:

The BioCollective is a microbiome innovation engine powered by samples and metadata . We collect the entire stool along with rich meta data from our members and metagenomic data from the sample. We collect data on 6 of the top 7 indicators of microbiome diversity and health from the Flemish population study. We have developed the BioFlux™ Metabolomic Model for in silico product development or existing product/drug/chemical impact testing on the metabolic output of the microbiome. We target the "most wanted" microbes for isolation and culture, currently curating a collection of bespoke microbes from diverse sources, including the deep sea. We do shotgun metagenomics and are building a unique data set to enable personalize medicine by bringing rich CONTEXT to the samples. A microbiome ecosystem is built over a lifetime, we collect the story to go with the sample. This has enabled us very quickly to identify targets and develop groundbreaking probiotics to restore the internal pharmacy. Collection, Connection, Correct- The answers are inside us.

Total Funding Amount:

$3.23M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Centennial, Colorado, United States

Founded Date:

2015-06-01

Contact Email:

martha.carlin(AT)thebiocollective.com

Founders:

Martha Carlin

Number of Employees:

1-10

Last Funding Date:

2020-02-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai